Biomedical Interventions

Each class of drug targets a different chemical system. Antidepressants, especially reuptake inhibitors, boost levels of serotonin or norepinephrine left in the synapse by blocking their reabsorption into the sending neuron. Antianxiety drugs usually enhance GABA, the brain's main calming neurotransmitter, which quiets overactive neural firing. Lithium stabilizes mood swings in bipolar disorder, though its exact mechanism is less precisely understood than the others. Antipsychotics mainly block dopamine receptors, which reduces symptoms like hallucinations and delusions linked to excess dopamine activity.

The weeks-long delay between taking a pill and feeling better is the key puzzle. A reuptake inhibitor raises synaptic serotonin almost immediately, within hours, because blocking reuptake is a fast chemical event. But mood does not lift that fast. Receptors on the receiving neuron have to adjust their sensitivity over time, and deeper changes in neural connections and brain adaptation build gradually. The chemical shift is immediate; the brain's remodeling in response to it is slow, and that remodeling seems to be what actually relieves the mood symptoms.

When drugs fail or symptoms are severe, direct brain stimulation is the next step. Transcranial magnetic stimulation uses magnetic pulses aimed at a specific brain region, typically to ease depression, with mild side effects and no memory loss. Electroconvulsive therapy sends a controlled electrical current through the brain to trigger a brief seizure, a stronger intervention reserved for severe, treatment-resistant depression, and it can cause temporary memory loss. Both act on the brain's electrical activity rather than its chemistry, placing them alongside drug therapy as tools that physically change how the brain functions.